What the Allergist Needs to Know about Monoclonal Antibody Therapy
Price: FREE for members, $25 for non-members
This webinar addresses key information that allergists need to know regarding the FDA Emergency Use Authorization of monoclonal antibodies in the treatment of COVID-19.
This webinar is sponsored by GlaxoSmithKline.
- Apply the most current FDA guidelines for the use of monoclonal antibodies.
- Describe the mechanisms and current data
- Evaluate their COVID-19 patients using the High-Risk Criteria for appropriate use of monoclonal antibody therapy
- Describe benefits and risks and special considerations of these therapies and procedures to refer for administration
Daniel Ein, MD, FACAAI Emeritus
Lisa Davidson, MD, FIDSA
Gailen D. Marshall, MD, PhD, FACAAI